Subgroup-specific alternative splicing in medulloblastoma

Acta Neuropathologica

Volumn 123, Issue 4, 2012, Pages 485-499

  Dubuc, Adrian M ^a,b   Morrissy, A Sorana ^a   Kloosterhof, Nanne K ^c,d   Northcott, Paul A ^a,b   Yu, Emily P Y ^e   Shih, David ^a,b   Peacock, John ^a,b   Grajkowska, Wieslawa ^f   Van Meter, Timothy ^g   Eberhart, Charles G ^h   Pfister, Stefan ⁱ   Marra, Marco A ^j   Weiss, William A ^k   Scherer, Stephen W ^b,l   Rutka, James T ^a,b   French, Pim J ^c   Taylor, Michael D ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j BRITISH COLUMBIA CANCER AGENCY   (Canada)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

more..

Author keywords

Alternative splicing; Medulloblastoma; Molecular subgroup; Neuronal development; Pediatric cancer

Indexed keywords

WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BRAIN DEVELOPMENT; CEREBELLUM; CLUSTER ANALYSIS; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ADULT; ALTERNATIVE SPLICING; CEREBELLAR NEOPLASMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FETUS; GENE EXPRESSION PROFILING; HEDGEHOG PROTEINS; HUMANS; KV1.1 POTASSIUM CHANNEL; MEDULLOBLASTOMA; MICROARRAY ANALYSIS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REPRODUCIBILITY OF RESULTS; WNT PROTEINS;

EID: 84862688169     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-0959-7     Document Type: Article

References (65)

1. Abouantoun TJ, MacDonald TJ (2009) Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor. Mol Cancer Ther 8(5):1137-1147
2. Alló M, Buggiano V, Fededa JP, Petrillo E, Schor I et al (2009) Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol 16(7):717-724
3. Bark C, Bellinger FP, Kaushal A, Mathews JR, Partridge LD et al (2004) Developmentally regulated switch in alternatively spliced SNAP-25 isoforms alters facilitation of synaptic transmission. J Neurosci 24(40):8796-8805 (Pubitemid 39362974)
4. Bartel F, Taubert H, Harris LC (2002) Alternative and aberrant splicing ofMDM2mRNA in human cancer. Cancer Cell 2(1):9-15 (Pubitemid 41043984)
5. Bhatia B, Northcott PA, Hambardzumyan D, Govindarajan B, Brat DJ et al (2009) Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization. Cancer Res 69(18):7224-7234
6. Bruinsma SP, Baranski TJ (2007) Beta2-chimaerin in cancer signaling: connecting cell adhesion and MAP kinase activation. Cell Cycle 6(20):2440-2444 (Pubitemid 350058659)
7. Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M et al (2011) Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol 13(6):669-679
8. Buonamici S, Williams J, Morrissey M, Wang A, Guo R et al (2010) Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med 2(51): 51ra70
9. Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A et al (2011) Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 29(11):1424-1430
10. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N et al (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2(10):2366-2382
11. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24(21):2343-2364
12. Dubuc AM, Northcott PA, Mack S, Witt H, Pfister S et al (2010) The genetics of pediatric brain tumors. Curr Neurol Neurosci Rep 10(3):215-223
13. Eberhart CG (2011) Molecular diagnostics in embryonal brain tumors. Brain Pathol 21(1):96-104
14. Ellison DW (2010) Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 120(3):305-316
15. Evans HK, Weidman JR, Cowley DO, Jirtle RL (2005) Comparative phylogenetic analysis of blcap/nnat reveals eutherianspecific imprinted gene. Mol Biol Evol 22(8):1740-1748 (Pubitemid 41373585)
16. Fan W, Khalid N, Hallahan AR, Olson JM, Zhao LP (2006) A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data. Theor Biol Med Model 3:19
17. Ferretti E, Di Marcotullio L, Gessi M, Mattei T, Greco A et al (2006) Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. Oncogene 25(55):7267-7273 (Pubitemid 44809092)
18. French PJ, Peeters J, Horsman S, Duijm E, Siccama I et al (2007) Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Res 67(12):5635-5642 (Pubitemid 46984994)
19. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q et al (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7:325
20. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS et al (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature 468(7327):1095-1099
21. Gilbertson RJ (2011) Finding the perfect partner for medulloblastoma prognostication. J Clin Oncol 29(29):3841-3842
22. Hallahan AR, Pritchard JI, Chandraratna RAS, Ellenbogen RG, Geyer JR et al (2003) BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9(8):1033-1038 (Pubitemid 37021783)
23. Hilmi C, Guyot M, PagésG(2012)VEGF spliced variants: possible role of anti-angiogenesis therapy. J Nucleic Acids 2012:162692
24. Ingham PW (1998) The patched gene in development and cancer. Curr Opin Genet Dev 8(1):88-94 (Pubitemid 28122146)
25. Kai M, Yasuda S, Imai S-I, Kanoh H, Sakane F (2007) Tyrosine phosphorylation of beta2-chimaerin by Src-family kinase negatively regulates its Rac-specific GAP activity. Biochim Biophys Acta 1773(9):1407-1415 (Pubitemid 47374845)
26. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M et al (2005) Antisense transcription in the mammalian transcriptome. Science 309(5740):1564-1566
27. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A et al (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PloS one 3(8):e3088
28. Kwan T, Benovoy D, Dias C, Gurd S, Serre D et al (2007) Heritability of alternative splicing in the human genome. Genome Res 17(8):1210-1218 (Pubitemid 47204865)
29. Leung T, How BE, Manser E, Lim L (1994) Cerebellar beta 2-chimaerin, a GTPase-activating protein for p21 ras-related rac is specifically expressed in granule cells and has a unique N-terminal SH2 domain. J Biol Chem 269(17):12888-12892
30. MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C et al (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29(2):143-152 (Pubitemid 32952650)
31. Maere S, Heymans K, Kuiper M (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21(16):3448-3449 (Pubitemid 41222459)
32. Mata MD, Alonso CR, Fededa JP, Pelisch F, Cramer P et al (2003) A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell 12(2):525-532 (Pubitemid 37238937)
33. Medrihan L, Rohlmann A, Fairless R, Andrae J, Döring M et al (2009) Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses. J Physiol 587(Pt 21):5095-5106
34. Menghi F, Jacques TS, Barenco M, Schwalbe EC, Clifford SC et al (2011) Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development. Cancer Res 71(6):2045-2055
35. Modrek B, Lee C (2002) A genomic view of alternative splicing. Nat Genet 30(1):13-19
36. Morrissy AS, Morin RD, Delaney A, Zeng T, McDonald H et al (2009) Next-generation tag sequencing for cancer gene expression profiling. Genome Res 19(10):1825-1835
37. Morrissy AS, Griffith M, Marra MA (2011) Extensive relationship between antisense transcription and alternative splicing in the human genome. Genome Res 21(8):1203-1212
38. Nagao K, Togawa N, Fujii K, Uchikawa H, Kohno Y et al (2005) Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays. Hum Mol Genet 14(22):3379-3388 (Pubitemid 41672122)
39. Nakajima A, Nishimura K, Nakaima Y, Oh T, Noguchi S et al (2009) Cell type-dependent proapoptotic role of Bcl2L12 revealed by a mutation concomitant with the disruption of the juxtaposed Irf3 gene. Proc Natl Acad Sci USA 106(30):12448-12452
40. Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463(7280):457-463
41. Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, Grajkowska W et al (2009) The miR-17/92 polycistron isup-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69(8):3249-3255
42. Northcott PA, Hielscher T, Dubuc A, Mack S, Shih D et al (2011) Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol 122(2):231-240
43. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29(11):1408-1414
44. Pfaff E, Remke M, Sturm D, Benner A, Witt H et al (2010) TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 28(35):5188-5196
45. Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C et al (2010) Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol 120(5):553-566
46. Pons S, Trejo JL, Martínez-Morales JR, Martí E (2001) Vitronectin regulates Sonic hedgehog activity during cerebellum development through CREB phosphorylation. Development 128(9):1481-1492 (Pubitemid 32514833)
47. Raffel C (2004) Medulloblastoma: molecular genetics and animal models. Neoplasia 6(4):310-322 (Pubitemid 38924846)
48. Remke M, Hielscher T, Korshunov A, Northcott PA, Bender S et al (2011) FSTL5 is a marker of poor prognosis in non-WNT/ non-SHH medulloblastoma. J Clin Oncol 29(29):3852-3861
49. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA et al (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361(12):1173-1178
50. Shearwin KE, Callen BP, Egan JB (2005) Transcriptional interference-a crash course. Trends Genet 21(6):339-345
51. Shendure J, Church GM (2002) Computational discovery of sense-antisense transcription in the human and mouse genomes. Genome Biol 3(99): RESEARCH0044
52. Storrs CH, Silverstein SJ (2007) PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6. J Virol 81(8):4080-4090 (Pubitemid 46586903)
53. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D et al (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24(12): 1924-1931 (Pubitemid 46638992)
54. Tijink BM, Buter J, de Bree R, Giaccone G, Lang MS et al (2006) A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus. Clin Cancer Res 12(20 Pt 1):6064-6072 (Pubitemid 44703770)
55. Tsang WH, Shek KF, Lee TY, Chow KL (2009) An evolutionarily conserved nested gene pair-Mab21 and Lrba/Nbea in metazoan. Genomics 94(3):177-187
56. Uchikawa H, Toyoda M, Nagao K, Miyauchi H, Nishikawa R et al (2006) Brain-and heart-specific Patched-1 containing exon 12b is a dominant negative isoform and is expressed in medulloblastomas. Biochem Biophys Res Commun 349(1):277-283 (Pubitemid 44339629)
57. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L et al (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456(7221):470-476 (Pubitemid 352759009)
58. Wang Z, Burge CB (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14(5):802-813 (Pubitemid 351574901)
59. Ward AJ, Cooper TA (2009) The pathobiology of splicing. J Pathol 220(2):152-163
60. Wei J, Zaika E, Zaika A (2012) p53 family: role of protein isoforms in human cancer. J Nucleic Acids 2012:687359
61. Werbowetski-Ogilvie TE, Seyed Sadr M, Jabado N, Angers-Loustau A, Agar NYR et al (2006) Inhibition of medulloblastoma cell invasion by Slit. Oncogene 25(37):5103-5112 (Pubitemid 44285979)
62. Xin D, Hu L, Kong X (2008) Alternative promoters influence alternative splicing at the genomic level. PloS one 3(6):e2377
63. Yang Z-J, Ellis T, Markant SL, Read T-A, Kessler JD et al (2008) Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14(2): 135-145
64. Zhang C, Li H-R, Fan J-B, Wang-Rodriguez J, Downs T et al (2006) Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinforma 7:202
65. Zhu H, Lo H-W (2010) The human glioma-associated oncogene homolog 1 (GLI1) family of transcription factors in gene regulation and diseases. Curr Genomics 11(4):238-245